Ron Burch

Dr. Burch has a 35 year history in biotech. His formal training was in pharmacology and chemistry, which was followed by a move to the NIH and then into a prolific biotech and pharma career. Ron has held senior research, director and VP roles at large pharma Zeneca and Purdue, and helpd several C-suite roles (CEO and CMO) and a number of biotechs.

Dr. Burch has acted as CMO and other senior positions for the clinical development of multiple diabetic neuropathic pain and chemotherapy-induced neuropathic pain drugs, and has unique insight into pain drug development along the development path from discovery to market from the industry and biotech perspectives. Dr. Burch is leading the clinical development plan for our diabetic neuropathic pain program.